Harrow (HROW) Other Accumulated Expenses (2022 - 2026)
Harrow (HROW) posted Other Accumulated Expenses of $106000.0 for Q1 2026, little changed on a QoQ basis from $106000.0 in Q4 2025, and little changed year-over-year from $106000.0 in Q1 2025.
Analysis
Harrow (HROW) Other Accumulated Expenses (2022 - 2026) Analysis & Trends
Harrow has reported Other Accumulated Expenses for 5 years, with the latest figure at $106000.0 in Q1 2026.
- On a quarterly basis, Other Accumulated Expenses changed 0.0% year-over-year to $106000.0 in Q1 2026; TTM through Mar 2026 was $106000.0, a 0.0% change from a year earlier, with the FY2025 full-year figure at $106000.0, changed 0.0% from the prior year.
- Other Accumulated Expenses was $106000.0 for Q1 2026 at Harrow, roughly flat from $106000.0 in the prior quarter.
- The five-year high for Other Accumulated Expenses was $139000.0 in Q4 2022, with the low at $89000.0 in Q4 2023.
- Average Other Accumulated Expenses over 5 years is $108000.0, with a median of $106000.0 recorded in 2024.
- The sharpest annual moves came in 2023 and 2024: Other Accumulated Expenses plunged 35.97% in 2023, then rose 19.1% in 2024.
- Over 5 years, Other Accumulated Expenses stood at $139000.0 in 2022, then slumped by 35.97% to $89000.0 in 2023, then grew by 19.1% to $106000.0 in 2024, then changed by 0.0% to $106000.0 in 2025, then changed by 0.0% to $106000.0 in 2026.
- The last three Other Accumulated Expenses figures came in at $106000.0 (Q1 2026), $106000.0 (Q4 2025), and $106000.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn |
| 10 | Harrow | 1.41 Bn | 1.32 Bn | 50.36 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 106,000.00 |
| Dec 31, 2025 | 106,000.00 |
| Sep 30, 2025 | 106,000.00 |
| Jun 30, 2025 | 106,000.00 |
| Mar 31, 2025 | 106,000.00 |
| Dec 31, 2024 | 106,000.00 |
| Dec 31, 2023 | 89,000.00 |
| Dec 31, 2022 | 139,000.00 |